Concepedia

Publication | Open Access

Down‐regulation of the cyclin‐dependent kinase inhibitor p57 is mediated by Jab1/Csn5 in hepatocarcinogenesis

49

Citations

40

References

2015

Year

Abstract

Jab1-p57 pathway confers resistance to chemotherapy and may represent a potential target for investigational therapy in HCC.

References

YearCitations

Page 1